| Financial Year |
March 31 2023 |
| Monetary Funds |
13,559,023,739.55 |
| Held-for-trading Financial Assets |
524,064,387.51 |
| Notes Receivable |
27,589,323.20 |
| Accounts Receivable |
8,234,345,579.24 |
| Advances to Suppliers |
10,538,862,389.99 |
| Other Receivables |
664,951,751.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
7,735,489.60 |
| Inventories |
10,018,445,636.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
27,403,955.98 |
| Other Current Assets |
411,197,703.77 |
| Total Current Assets |
45,730,912,214.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
106,579,161.86 |
| Long-term Equity Investment |
773,641,274.62 |
| Investment Properties |
31,166,879.07 |
| Fixed Assetes |
5,344,799,049.97 |
| Under-construction Projects |
18,063,990.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
696,157,960.96 |
| R&D expenses |
7,083,590.08 |
| Goodwill |
55,698,586.32 |
| Long-Term Deferred and Prepaid Expenses |
65,513,281.41 |
| Deferred Income Tax Assets |
320,701,585.12 |
| Other Non-Current Assets |
107,711,007.63 |
| Sub-Total of Non-Current Assets |
9,399,826,872.52 |
| Total Assets |
55,130,739,086.78 |
| Short-Term Loans |
3,929,605,255.77 |
| Trading Financial liabilities |
109,454,958.27 |
| Notes Payable |
8,438,575,232.58 |
| Accounts Payable |
7,115,051,446.27 |
| Accounts Received In Advance |
336,410.27 |
| Employee Compensation Payable |
131,547,011.76 |
| Taxes Payable |
435,360,445.14 |
| Interest Payable |
-- |
| Dividend Payable |
65,855,263.00 |
| Other payables |
1,316,646,456.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
472,940,104.24 |
| Other Current Liabilities |
1,614,751,842.52 |
| Sub-Total of Current Liabilities |
38,842,085,791.17 |
| Long-term Loans |
328,358,888.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
272,546,723.62 |
| Deferred Income Tax Liabilities |
135,367,955.14 |
| Other Non-Current Liabilities |
2,238,626.24 |
| Sub-Total of Non-Current Liabilities |
2,300,117,153.15 |
| Total Liabilities |
41,142,202,944.32 |
| Paid-In Capital(Or Share Stock) |
1,306,749,434.00 |
| Capital Surplus |
1,177,848,505.04 |
| Surplus Reserve |
357,240,358.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,497,428,445.81 |
| Minority Stockholder's Interest |
7,486,683,918.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,501,852,224.05 |
| Owner's Equity（Stockholder's Equity） |
13,988,536,142.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
55,130,739,086.78 |
